Ecstasy (MDMA) toxicity: Difference between revisions
| Line 17: | Line 17: | ||
*[[Seizure]] | *[[Seizure]] | ||
*[[Serotonin syndrome]] | *[[Serotonin syndrome]] | ||
{| class="wikitable" | |||
|- | |||
! System | |||
! Minor or moderate overdose || Severe overdose | |||
|- | |||
! Cardiovascular | |||
| | |||
|| | |||
* [[Disseminated intravascular coagulation]] | |||
* [[Intracranial hemorrhage]] | |||
* Severe [[hypertension]] or [[hypotension]] | |||
* Hypotensive bleeding | |||
|- | |||
! Central nervous<br />system | |||
| | |||
* Hyperreflexia | |||
* Agitation | |||
* Confusion | |||
* Paranoia | |||
* Stimulant psychosis | |||
| | |||
* Cognitive deficit | |||
* Coma | |||
* Convulsions | |||
* [[Hallucinations]] | |||
* Loss of consciousness | |||
* [[Serotonin syndrome]] | |||
|- | |||
! Musculoskeletal | |||
| | |||
| | |||
* Hypertonia | |||
* [[Rhabdomyolysis]] | |||
|- | |||
! Respiratory | |||
| | |||
| | |||
* [[Acute respiratory distress syndrome]] | |||
|- | |||
! Urinary | |||
| | |||
| | |||
* [[Acute kidney injury]] | |||
|- | |||
! Other | |||
| | |||
| | |||
* Cerebral edema | |||
* [[Hepatitis]] | |||
* [[Hyperpyrexia]] | |||
* [[Hyponatremia]] (SIADH) | |||
|} | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Revision as of 05:33, 6 September 2019
Background
- 3,4-methylenedioxymethamphetamine (MDMA)
- Also known as: X, Molly, Skittles, Smartees, Beans
- Popular at "rave" parties and EDM festivals
- Causes catecholamine release, serotonin release, and inhibits serotonin re-uptake
- 1-2mg/kg effective dose; onset 30min-1 hour, peak 4 hours, lasts 8-24 hours
- Typical tablets contain 50-100mg of MDMA
Clinical Features
- Euphoria
- Agitation
- Tachycardia, palpitations, hypertension
- Hyperthermia
- Hyponatremia (from sweat loss, free water intake, and SIADH-like effect) [1]
- Seizure
- Serotonin syndrome
| System | Minor or moderate overdose | Severe overdose |
|---|---|---|
| Cardiovascular |
| |
| Central nervous system |
|
|
| Musculoskeletal |
| |
| Respiratory | ||
| Urinary | ||
| Other |
|
Differential Diagnosis
Sympathomimetics
- Cocaine
- Amphetamines
- Synthetic cathinones (khat)
- Ketamine
- Ecstasy (MDMA)
- Synthetic cannabinoids
- Bath salts
Drugs of abuse
- 25C-NBOMe
- Alcohol
- Amphetamines
- Bath salts
- Cocaine
- Ecstasy
- Gamma hydroxybutyrate (GHB)
- Heroin
- Inhalant abuse
- Hydrocarbon toxicity
- Difluoroethane (electronics duster)
- Marijuana
- Kratom
- Phencyclidine (PCP)
- Psilocybin ("magic mushrooms")
- Synthetic cannabinoids
- Chloral hydrate
- Body packing
Evaluation
Hallucination workup
- Urine pregnancy
- CBC, Metabolic panel, LFTs, coags, APAP level, ASA level
- Total CK level
- ECG
- UA
- Tox screen, blood alcohol
- Serum osmoles, urine Na (if Hyponatremia present)
- Head CT as indicated
- LP to rule out Meningitis if infectious symptoms and based on history and physical
- Urine tox fails to detect unless large doses
- More usually positive test for amphetamines
- Confirmation must use specialized lab tests (gas chromatography)
Management
- Supportive care is mainstay of treatment
- Benzodiazepines for agitation, severe hypertension
- Hyperthermia may be severe and requires immediate treatment with active cooling measures
- Morbidity/mortality is related to severity and length of hyperthermia
Disposition
- Consider discharge if all symptoms resolve and no complications noted
- Otherwise admit
References
- ↑ Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. J Psychopharmacol. 2012;26(3):408-18

